The Zimbabwe Pharmaceutical Industry Conference
The Zimbabwe Pharmaceutical Industry Conference 2026 | 3 – 5 September 2026, Rainbow Towers, HarareThe Zimbabwe Pharmaceutical Industry Conference 2026 | 3 – 5 September 2026, Rainbow Towers, HarareThe Zimbabwe Pharmaceutical Industry Conference 2026 | 3 – 5 September 2026, Rainbow Towers, Harare
+263 78 117 0515
registration@zimpharmaconference.com
Harare

Articles and Abstracts

  • Home
  • Articles and Abstracts

Beyond the Counter: Re-evaluating Dietary Fats and the Therapeutic Edge of Canola Oil

CLINICAL NUTRITION & PHARMACY PRACTICE Beyond the Counter: Re-evaluating Dietary Fats and the Therapeutic Edge of Canola Oil Prepared by: Munamba Patrick. BPharm.Msc. ICPN In community practice and clinical consultations, pharmacists routinely field questions regarding metabolic health, cardiovascular risk reduction, and lifestyle interventions. While pharmacological therapies remain a cornerstone of…
Read More

Beyond Evidence Generation: How Clinical Research Strengthens Zimbabwe’s Pharmaceutical Ecosystem

Siphosami Musikavanhu, BPharm (Hons), CTGU Clinical Research Pharmacy Lead, Africa Clinical Research Network, Harare, Zimbabwe Introduction: Pharmaceutical resilience is more than manufacturing Discussions about pharmaceutical resilience in Zimbabwe often focus on local manufacturing, regulation, procurement and access to quality-assured medicines. National policy identifies domestic production as a priority.1 Manufacturers work…
Read More

Digital pharmaceutical care and the fight against overuse and abuse of Tramadol : Towards an innovative pharmaceutical business opportunity.

Mutsiwa, RM1, Munkombwe, D2 and Nyazema, NZ3 STM Pharmaceuticals1, Department of Pharmacy, University of Zambia2 and Department of Clinical Pharmacology, University of Zimbabwe3 Only about 1% of the opioids used worldwide is distributed to low-income countries, hence the clamour for increased opioid use in recent years. However, these efforts may…
Read More

Toward a Sustainable, Resilient Pharmaceutical Value Chain in Africa

by Dr Lloyd Matowe The COVID-19 pandemic exposed a fundamental weakness in Africa’s pharmaceutical systems: when global supply chains fail, the continent faces acute shortages of medicines, raw materials, diagnostics and other essential health products. Border closures, export restrictions, manufacturing interruptions and transport constraints revealed the cost of excessive dependence…
Read More

Development of a Paediatric Ciprofloxacin Dry Powder for Reconstitution Using the Ionic Gelation Method for Effective Taste-Masking

Authors: Tinovimba K. Nazare1, Tawanda L. Samupindi2 Affiliations: 1Pharmacy Department, Harare Institute of Technology, Harare, Zimbabwe 2Zimbabwe Pharmaceutical Students Association, Harare Institute of Technology Chapter. Corresponding Author: Tinovimba K. Nazare Contact: +263 786931447 Email: tinovimbanaz@gmail.com Paediatric medication non-adherence resulting from the intense bitterness of ciprofloxacin remains a major contributor to…
Read More

Zimbabwe Pharmaceutical Ecosystem and Productive Private-Public-Partnerships: Towards improved health outcomes and greater cost effectiveness in the health system

by Prof Norman Z. Nyazema, Context After independence in 1980, the health landscape in Zimbabwe underwent rapid transformation. Today in Zimbabwe some people are now living longer and the rate of infant mortality has been reduced. The disease burden appears to be increasingly defined by disability instead of premature mortality.…
Read More
Shopping Cart (0 items)